Role of Global Surveillance in Combating Bacterial Resistance
- 作者Anna Marchese, Dr Gian Carlo Schito
- 卷第61卷
- 期第2期
- 文件大小156.19KB
- 发表时间2001-02
- DOI10.2165/00003495-200161020-00002
- 页码167-173
Pharmacokinetic interaction between amprenavir and delavirdine: Evidence of induced clearance by amprenavirTran, J · 2002
Effect of reduced-dose amprenavir in combination with lopinavir on plasma levels of amprenavir in patients infected with HIVAllan J. Stein; Cynthia H. Brothers; Trevor R. Scott · 2001
Treatment with Amprenavir Alone or Amprenavir with Zidovudine and Lamivudine in Adults with Human Immunodeficiency Virus InfectionMurphy, Robert L.; Gulick, Roy M.; DeGruttola, Victor; D'Aquila, Richard T.; Eron, Joseph J.; Sommadossi, Jean‐Pierre; Currier, Judith S.; Smeaton, Laura; Frank, Ian; Caliendo, Angela M.; Gerber, John G.; Tung, Roger; Kuritzkes, Daniel R. · The Journal of Infectious Diseases · 1999
Treatment with Amprenavir Alone or Amprenavir with Zidovudine and Lamivudine in Adults with Human Immunodeficiency Virus InfectionRobert L. Murphy, Roy M. Gulick, Victor DeGruttola, Richard T. D'Aquila, Joseph J. Eron, Jean-Pierre Sommadossi, Judith S. Currier, Laura Smeaton, Ian Frank, Angela M. Caliendo, John G. Gerber, Roger Tung and Daniel R. Kuritzkes · The Journal of Infectious Diseases · 1999
Amprenavir Inhibitory Quotient and Virological Response in Human Immunodeficiency Virus-Infected Patients on an Amprenavir-Containing Salvage Regimen without or with RitonavirDuval, X.; Lamotte, C.; Race, E.; Descamps, D.; Damond, F.; Clavel, F.; Leport, C.; Peytavin, G.; Vilde, J.-L. · Antimicrobial Agents and Chemotherapy · 2002
Structural and Kinetic Analyses of the Protease from an Amprenavir-Resistant Human Immunodeficiency Virus Type 1 Mutant Rendered Resistant to Saquinavir and Resensitized to AmprenavirMarkland, W.; Rao, B. G.; Parsons, J. D.; Black, J.; Zuchowski, L.; Tisdale, M.; Tung, R. · Journal of Virology · 2000
Twice-daily amprenavir 1200 mg versus amprenavir 600 mg/ritonavir 100 mg, in combination with at least 2 other antiretroviral drugs, in HIV-1-infected patientsJeffrey P Nadler; Joseph C Gathe; Richard B Pollard; Gary J Richmond; Qiming Liao; Sandy Griffith; C Tracey Lancaster; Jaime E Hernandez; Keith A Pappa; the ESS40011 (STARR) Study Team · 2003
AmprenavirJulie C. Adkins, Diana Faulds · 1998
GemcitabineStuart Noble, Karen L. Goa · 1997
EptifibatideKaren L. Goa, Stuart Noble · 1999
Adefovir DipivoxilStuart Noble, Karen L. Goa · 1999
PerindoprilDene Simpson, Stuart Noble, Karen L. Goa · 2002
Insulin AspartTherese M. Chapman, Stuart Noble, Karen L. Goa · 2002
Panipenem/BetamipronKaren L. Goa, Stuart Noble · 2003
EnoxaparinNoble, Stuart; Peters, David H.; Goa, Karen L. · Drugs · 1995